BIO-Europe 2022

Join EVERSANA™ at BIO-Europe, October 24–26, 2022 in Leipzig, Germany. With over 40 clients and a growing number of engagements in Europe, EVERSANA is leading the way as the only end-to-end provider of commercialisation services that span all stages of the product life cycle to deliver long-term value for patients, physicians and payers.

Join our team for networking during BIO-Europe or watch our experts speak during the following sessions.

  • Panel Discussion: Challenging Tradition: The Argument for Integrated Commercialisation
    In this session, EVERSANA’s Ashely Cox, Senior Principal, EVERSANA MANAGEMENT CONSULTING joins industry experts to discuss options beyond the traditional partnering structures.  Each potential structure will be explored to understand the potential opportunities and challenges associated with the development and commercialisation of a novel asset.

 

 


Stay current with the latest commercialisation news:

Shorla Pharma Announces Partnership with EVERSANA to Support the Launch and Commercialization of T-cell Leukemia Treatment

EVERSANA™ expands medical information and integrated compliance services across Europe

Explore services:

U.S. Commercialisation

Assess Commercial Readiness in Europe